These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 83218)

  • 61. [Plasma substitutes].
    Lutz H
    Dtsch Med Wochenschr; 1969 Jun; 94(25):1336-9. PubMed ID: 4182110
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effect of hydroxyethyl starch on blood volume and extracellular fluid volume during hemorrhage--comparison with the effect of clinical dextran and re-infusion of autologous blood].
    Ikeda K; Tanaka S; Mizutani H; Horii D; Arai Y
    Masui; 1971 Jul; 20(7):639-47. PubMed ID: 5105401
    [No Abstract]   [Full Text] [Related]  

  • 63. [MEASURES FOR THE PREVENTION OF HEPATITIS AFTER BLOOD TRANSFUSION, WITH SPECIAL REFERENCE TO PLASMA SUBSTITUTES].
    MIZUMO A
    Naika; 1964 Jul; 14():71-5. PubMed ID: 14174360
    [No Abstract]   [Full Text] [Related]  

  • 64. Colloids and renal dysfunction: another brick in the wall of safety concerns.
    Erstad BL
    Crit Care Med; 2011 Jun; 39(6):1565-6. PubMed ID: 21610625
    [No Abstract]   [Full Text] [Related]  

  • 65. Blood component therapy in anaesthetic practice.
    Blajchman MA; Herst R; Perrault RA
    Can Anaesth Soc J; 1983 Jul; 30(4):382-9. PubMed ID: 6347352
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effect of kidney function on the elimination and action of colloidal plasma substitutes].
    Köhler H
    Fortschr Med; 1979 Oct; 97(40):1809-13. PubMed ID: 94298
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinico-immunologic aspects of the differentiated use of plasma substitutes in the complex treatment of various bronchopulmonary diseases].
    Provotorov VM; Nikitin AV; Petrov AV
    Ter Arkh; 1985; 57(10):89-94. PubMed ID: 2417345
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Colloid infusion and haemodilution after severe HAEMORRHAGE.
    Lancet; 1967 May; 1(7500):1145. PubMed ID: 4164798
    [No Abstract]   [Full Text] [Related]  

  • 69. [Prolongation of thrombolytin and heparin action by synthetic blood substitutes].
    Andreev SD
    Sov Med; 1971 Jul; 34(7):89-94. PubMed ID: 5160340
    [No Abstract]   [Full Text] [Related]  

  • 70. [Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
    Köhler H; Kirch W; Horstmann HJ
    Anaesthesist; 1977 Nov; 26(11):623-7. PubMed ID: 74216
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Use of transfusion media for treatment of children with traumatic shock].
    Liberzon DM; Strel'nikova OA
    Probl Gematol Pereliv Krovi; 1976 Aug; 21(8):13-7. PubMed ID: 967837
    [No Abstract]   [Full Text] [Related]  

  • 72. Scope and limitations of therapy with plasma substitutes: differential indication for substitutes, blood preparations and electrolyte solutions.
    Reissigl H
    Bibl Haematol; 1969; 33():32-54. PubMed ID: 4914355
    [No Abstract]   [Full Text] [Related]  

  • 73. [Small volume--large benefits?].
    Kreimeier U; Peter K; Messmer K
    Anaesthesist; 2001 Jun; 50(6):442-9. PubMed ID: 11463052
    [No Abstract]   [Full Text] [Related]  

  • 74. [Blood substitution by plasma expanders and the reactions in the blood coagulation system].
    Pfeifer G
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):720-4. PubMed ID: 5295914
    [No Abstract]   [Full Text] [Related]  

  • 75. [Hydroxyethyl starch: Statement of the Presidents of DGAI and the BDA and the President of the DAAF].
    Werner C; Geldner G; Koch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):437. PubMed ID: 23929160
    [No Abstract]   [Full Text] [Related]  

  • 76. Intravenous fluid therapy in severe trauma.
    Bank J
    S Afr Med J; 1972 Jan; 46(2):36-7. PubMed ID: 5058500
    [No Abstract]   [Full Text] [Related]  

  • 77. [Effects and adverse effects of colloid-containing solutions].
    Bergmann H
    Beitr Infusionther Klin Ernahr; 1979; 2():43-50. PubMed ID: 94260
    [No Abstract]   [Full Text] [Related]  

  • 78. The use of high-volume 6% hydroxyethyl starch 130/0.4 in massive obstetric hemorrhage.
    Yu G; Changjun G; Yan C
    Int J Obstet Anesth; 2013 Nov; 22(4):360-1. PubMed ID: 23993474
    [No Abstract]   [Full Text] [Related]  

  • 79. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison.
    Bayer O; Reinhart K; Sakr Y; Kabisch B; Kohl M; Riedemann NC; Bauer M; Settmacher U; Hekmat K; Hartog CS
    Crit Care Med; 2011 Jun; 39(6):1335-42. PubMed ID: 21358396
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The influence of different plasma substitutes on blood clotting and platelet function during and after operations (author's transl)].
    Harke H; Thoenies R; Margraf I; Momsen W
    Anaesthesist; 1976 Aug; 25(8):366-73. PubMed ID: 60065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.